Journal of Nuclear Medicine September 2024, jnumed.124.268145; DOI: https://doi.org/10.2967/jnumed.124.268145 ...
Validation of a Simplified Tissue-to-Reference Ratio Measurement Using SUVR to Assess Synaptic Density Alterations in Alzheimer Disease with [11 C]UCB-J PET ...
Journal of Nuclear Medicine September 2024, jnumed.124.267624; DOI: https://doi.org/10.2967/jnumed.124.267624 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267736; DOI: https://doi.org/10.2967/jnumed.124.267736 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267964; DOI: https://doi.org/10.2967/jnumed.124.267964 ...
Journal of Nuclear Medicine September 2024, jnumed.123.267215; DOI: https://doi.org/10.2967/jnumed.123.267215 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267578; DOI: https://doi.org/10.2967/jnumed.124.267578 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267751; DOI: https://doi.org/10.2967/jnumed.124.267751 ...
Journal of Nuclear Medicine September 2024, jnumed.123.267274; DOI: https://doi.org/10.2967/jnumed.123.267274 ...
Nuclear medicine for therapeutic purposes, here termed molecular radiotherapy (MRT), is a rapidly developing field, mostly in the context of metastatic cancer treatment. It is self-evident that ...
FINDing the radiopharma future: Behrenbruch provides perspective on the effects of radiopharmaceutical regulatory reforms and highlights the potential of the Facilitating Innovative Nuclear ...